Understand the source comparison
How the 2025–2026 Market Shift Changed US vs China Peptides
The collapse of several major peptide vendors in 2025 and 2026 created a sharp demand shift toward verified US manufacturing. Peptide Sciences shut down in March 2026 under regulatory pressure. Amino Asylum was raided in 2025. Paradigm Peptides’ founders pled
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The collapse of several major peptide vendors in 2025 and 2026 created a sharp demand shift toward verified US manufacturing. Peptide Sciences shut down in March 2026 under regulatory pressure. Amino Asylum was raided in 2025. Paradigm Peptides’ founders pled guilty to federal charges in December 2025. The cumulative effect pushed a large volume of research buyers toward domestic alternatives.
- The US vs China peptides decision is now being made in a market where trust signals matter more than ever. Researchers seeking detailed coverage of the shutdowns can read the Amino Asylum and Paradigm Peptides analysis, the current alternatives ranked in best peptide companies 2026, and a dedicated Peptide Sciences alternative analysis.